First of many meetings to come that are required by the Drug Supply Chain Security Act
FDA has posted a Federal Register announcement of a public workshop to be held May 8-9 at its Silver Spring, MD, campus. This is the first of many meetings that are specified in Title II of the Drug Quality and Security Act passed last November (Title II is being called the Drug Supply Chain Security Act, or DSCSA, by FDA).
The subject of the meeting is: “Standards for the Interoperable Exchange of Information for Tracing of Human, Finished, Prescription Drugs, in Paper or Electronic Format,” which refers, at one level, to how barcode information on drugs are to be incorporated into packaging, and at another level to a trio of regulatory items, “Transaction Information,” “Transaction History” and “Transaction Statement,” that are the documentation of product movement through supply chains. FDA has had a docket open since February soliciting comments on these topics.
Registration information is available here.
Elevate Your Commercial Operations with Close-up CRM
September 6th 2024Discover a powerful, cost-effective, and robust CRM platform that maximizes your budget. Seamlessly integrate data from any source, streamline marketing efforts, and optimize HCP promotion, key account management, and digital marketing campaigns. Reduce CRM costs and reallocate funds to enhance data analytics, market research, and human capital, boosting overall commercial operations impact.
AI-Enabled Pharma CRM Driving Intelligent Customer Engagement
September 6th 2024Discover our unparalleled CRM solution that integrates AI/ML for enhanced stability, security, and performance. Leverage our team of 1000+ experts and 25K+ data provider partners. Our cloud-based SaaS model allows rapid global deployment and scalability, while our clean UX focuses on intuitive AI experience and rapid user adoption. Ensure swift 80% physician onboarding with our intuitive AI platform, speeding strategic integration.